These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417 [TBL] [Abstract][Full Text] [Related]
3. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Wall SC; Gu H; Rudnick G Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252 [TBL] [Abstract][Full Text] [Related]
4. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters. Yu H; Kim IJ; Folk JE; Tian X; Rothman RB; Baumann MH; Dersch CM; Flippen-Anderson JL; Parrish D; Jacobson AE; Rice KC J Med Chem; 2004 May; 47(10):2624-34. PubMed ID: 15115403 [TBL] [Abstract][Full Text] [Related]
6. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Wall SC; Innis RB; Rudnick G Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827 [TBL] [Abstract][Full Text] [Related]
7. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. Jones DC; Lau SS; Monks TJ J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827 [TBL] [Abstract][Full Text] [Related]
8. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Rudnick G; Wall SC Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1817-21. PubMed ID: 1347426 [TBL] [Abstract][Full Text] [Related]
9. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X; Baumann MH; Xu H; Rothman RB Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556 [TBL] [Abstract][Full Text] [Related]
11. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs. Hoffman BJ Pharmacopsychiatry; 1994 Jan; 27(1):16-22. PubMed ID: 8159777 [TBL] [Abstract][Full Text] [Related]
12. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter. Rudnick G; Wall SC Mol Pharmacol; 1991 Sep; 40(3):421-6. PubMed ID: 1896028 [TBL] [Abstract][Full Text] [Related]
13. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929 [TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). Ansah TA; Ramamoorthy S; MontaƱez S; Daws LC; Blakely RD J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658 [TBL] [Abstract][Full Text] [Related]
15. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter. Dutta AK; Xu C; Reith ME J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474 [TBL] [Abstract][Full Text] [Related]
16. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine. Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792 [TBL] [Abstract][Full Text] [Related]
17. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876 [TBL] [Abstract][Full Text] [Related]
18. Release of dopamine via the human transporter. Eshleman AJ; Henningsen RA; Neve KA; Janowsky A Mol Pharmacol; 1994 Feb; 45(2):312-6. PubMed ID: 7906856 [TBL] [Abstract][Full Text] [Related]
19. Antidepressant binding to the porcine and human platelet serotonin transporters. Humphreys CJ; Levin J; Rudnick G Mol Pharmacol; 1988 Jun; 33(6):657-63. PubMed ID: 3380080 [TBL] [Abstract][Full Text] [Related]
20. Human placental monoamine transporters as targets for amphetamines. Ramamoorthy JD; Ramamoorthy S; Leibach FH; Ganapathy V Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]